NorthWest Health Prop Real Est Inv Trust - NWH.UN Stock Forecast, Price & News

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies. With a fully integrated and aligned senior management team, the REIT leverages 230 professionals across nine offices in five countries to serve as a long-term real estate partner to leading healthcare operators.

NorthWest Health Prop Real Est Inv Trust Trading Up 0.5 %

Shares of TSE:NWH.UN traded up C$0.06 during midday trading on Thursday, hitting C$13.12. The company had a trading volume of 209,600 shares, compared to its average volume of 495,682. The company has a current ratio of 0.21, a quick ratio of 0.21 and a debt-to-equity ratio of 85.42. NorthWest Health Prop Real Est Inv Trust has a 12 month low of C$11.85 and a 12 month high of C$14.42. The firm has a fifty day simple moving average of C$12.61 and a 200 day simple moving average of C$13.17. The stock has a market cap of C$2.82 billion and a price-to-earnings ratio of 7.22.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on NWH.UN shares. National Bankshares dropped their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$15.50 to C$14.00 in a research note on Tuesday. CIBC cut their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$15.50 to C$14.75 in a research note on Monday, June 27th. Finally, BMO Capital Markets upgraded NorthWest Health Prop Real Est Inv Trust from a "market perform" rating to a "buy" rating and lowered their price objective for the company from C$15.00 to C$13.75 in a research note on Monday, July 4th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of C$14.97.